InvestorsHub Logo
Followers 144
Posts 8676
Boards Moderated 0
Alias Born 10/07/2013

Re: birzinho post# 28484

Sunday, 06/01/2014 1:07:51 PM

Sunday, June 01, 2014 1:07:51 PM

Post# of 426566
Hi birzinho,

I posted the link for page smile It takes time:
- this news will be known by wider audience (ie.: article in The Street)
- ‘enactment of this Act’ will not be tomorrow (as somebody wrote it could be several months)
- I think the FDA will take into account the Senate / House statement during the appeal process, but not with immediate reaction. I mean they will not reinstate it tomorrow, but it will be definitely reflected in the OND’s answer expected by July / August.

Hi sts66,

AMRN does not have to quit: ‘Although the indication strictly speaks to reduction in lipoprotein levels and improvement in numbers, this indication for this population certainly implies that one should expect cardiovascular benefit from treatment.’ by FDA / Mary Roberts, Oct 16 AdCom.

Vascepa sales will be more decent with KOWA at the time of ANCHOR approval.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News